Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cutaneous T-cell lymphomas: Focusing on novel agents in relapsed and refractory disease
Lisa Argnani, Alessandro Broccoli, Pier Luigi Zinzani
Cancer Treatment Reviews (2017) Vol. 61, pp. 61-69
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Nuclear receptors: recent drug discovery for cancer therapies
Linjie Zhao, Shengtao Zhou, Jan-Ακε Gustafsson
Endocrine Reviews (2019)
Open Access | Times Cited: 140
Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma
Keisuke Watanabe, Angela M. Gomez, Shunichiro Kuramitsu, et al.
Blood Advances (2023) Vol. 7, Iss. 14, pp. 3416-3430
Open Access | Times Cited: 24
The ubiquitin ligase RNF5 determines acute myeloid leukemia growth and susceptibility to histone deacetylase inhibitors
Ali Khateb, Anagha Deshpande, Yongmei Feng, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 43
Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferation
Ieva Saulīte, Desislava Ignatova, Yun‐Tsan Chang, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 40
Natural compounds targeting nuclear receptors for effective cancer therapy
Mangala Hegde, Sosmitha Girisa, Nikunj Naliyadhara, et al.
Cancer and Metastasis Reviews (2022) Vol. 42, Iss. 3, pp. 765-822
Closed Access | Times Cited: 23
Implication of protein post translational modifications in gastric cancer
Houji Song, Mingze Zhang, Chengwang Guo, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Advances in classification and treatment of primary cutaneous lymphomas
Hong Zheng, Lihua Qiu, Chang Liu, et al.
Annals of Hematology (2025)
Open Access
First Occurrence of Plasmablastic Lymphoma in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Disease Patient and Review of the Literature
Maddalena Migliavacca, Andrea Assanelli, Maurilio Ponzoni, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 30
Cusatuzumab for treatment of CD70‐positive relapsed or refractory cutaneous T‐cell lymphoma
Nicolas Leupin, Pier Luigi Zinzani, Franck Morschhauser, et al.
Cancer (2021) Vol. 128, Iss. 5, pp. 1004-1014
Closed Access | Times Cited: 18
CAR-Based Approaches to Cutaneous T-Cell Lymphoma
Irene Scarfò, Matthew J. Frigault, Marcela V. Maus
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 21
Transcriptome‑based drug repositioning identifies TPCA‑1 as a potential selective inhibitor of esophagus squamous carcinoma cell viability
Zongyang Li, Linjun Zou, Zhi‐Xiong Jim Xiao, et al.
International Journal of Molecular Medicine (2022) Vol. 49, Iss. 6
Open Access | Times Cited: 11
MiR-449a attenuates autophagy of T-cell lymphoma cells by downregulating ATG4B expression
Nan Zhang, Ling Qiu, Tao Li, et al.
BMB Reports (2020) Vol. 53, Iss. 5, pp. 254-259
Open Access | Times Cited: 14
PUVA and interferon α2b combined therapy for patients with mycosis fungoides at different stages of the disease: a seven‐year retrospective study in Russia
Olga Yu. Olisova, Matteo Megna, Ekaterina V. Grekova, et al.
Journal of the European Academy of Dermatology and Venereology (2018) Vol. 33, Iss. 2
Closed Access | Times Cited: 6
Impact of Donor Source on Allogeneic Hematopoietic Stem Cell Transplantation for Mature T Cell and Natural Killer Cell Neoplasms in the Kyoto Stem Cell Transplantation Group
Mizuki Watanabe, Junya Kanda, Yasuyuki Arai, et al.
Biology of Blood and Marrow Transplantation (2020) Vol. 26, Iss. 12, pp. 2346-2358
Closed Access | Times Cited: 4
B-cell lymphoma 2 inhibitor venetoclax treatment of a patient with cutaneous T-cell lymphoma
Amber Loren Ong King, Fatima N. Mirza, Julia M. Lewis, et al.
JAAD Case Reports (2020) Vol. 8, pp. 89-92
Open Access | Times Cited: 4
Cancer-Cell-Selective Targeting by Arylcyclopropylamine–Vorinostat Conjugates
Yosuke Ota, Yukihiro Itoh, Takashi Kurohara, et al.
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 10, pp. 1568-1573
Open Access | Times Cited: 3
Bexarotene Induce Differentiation of Myeloid-Derived Suppressor Cells through Arg-1 Signalling Pathway
Haozhou Wang, Yinan Guo, Xiaodong Zhang, et al.
Transplantation Proceedings (2024) Vol. 56, Iss. 6, pp. 1469-1477
Closed Access
A Retrospective Cohort Study to Determine Real-World Treatment Patterns in Patients with Sézary Syndrome in the United States
Robert Ristuccia, Yang Zhao, Chunlan Chang, et al.
Oncology and Therapy (2024)
Open Access
Real-world Use of Mogamulizumab Among Patients With Mycosis Fungoides and Sézary Syndrome Before and During COVID-19 in the United States
Chunlan Chang, Robert Ristuccia, Zhishui Zheng, et al.
Clinical Therapeutics (2024) Vol. 46, Iss. 12, pp. 1024-1033
Open Access
Kutane Lymphome
Marion Wobser, Matthias Goebeler
Der Hautarzt (2019) Vol. 70, Iss. 10, pp. 815-830
Closed Access | Times Cited: 3
Kutane Lymphome
Marion Wobser, Matthias Goebeler
Der Pathologe (2020) Vol. 41, Iss. 1, pp. 79-94
Closed Access | Times Cited: 2
Overexpression of STAT4 at early stages of mycosis fungoides: Coincidence or not?
Olga Yu. Olisova, Ekaterina V. Grekova, Zaletaev Dv, et al.
Australasian Journal of Dermatology (2020) Vol. 62, Iss. 1
Closed Access | Times Cited: 2
Ronald C.D. Breslow (1931–2017): A career in review
Joseph Vincent, Mindy Levine
Bioorganic Chemistry (2021) Vol. 115, pp. 104868-104868
Closed Access | Times Cited: 2
Potent Anticancer Effects of Epidithiodiketopiperazine NT1721 in Cutaneous T Cell Lymphoma
Min Lin, Claudia Kowolik, Jun Xie, et al.
Cancers (2021) Vol. 13, Iss. 13, pp. 3367-3367
Open Access | Times Cited: 2
A case report of the long treatment experience of a Sézary syndrome responder patient: 16 years through all the systemic and innovative therapies
Laura Nanni, Alice Morigi, Beatrice Casadei, et al.
Hematological Oncology (2019) Vol. 37, Iss. 2, pp. 202-204
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top